| Cancer survival among women differs by race | | Posted Wednesday, September 27, 2006 11:01:32 PM by Blog57 Team | | Black women with uterine cancer are more likely to die than white women, even when the progression of the disease is equal and they are given identical treatments, researchers report. The reasons for the disparity are unclear. The racial difference in survival among women with uterine cancer, sometimes called endometrial cancer, is well-known. The American Cancer Society estimates that 7 percent of the 41,000 cases of endometrial cancer last year were in black women, but they accounted for 14 percent of the 7,000 deaths. According to the National Cancer Institute, the five-year survival rate is 86 percent for white women and 54 percent for black women. In previous studies on the disease, the disparity had been attributed to differences in treatment received. A new study, however, looked at women enrolled in four controlled clinical trials, where the treatments were carefully designed to be identical without regard to the race of the patients.... | |
| |
| | | Common prostate cancer treatments no better than doing nothing ... | | Posted Thursday, August 17, 2006 9:04:38 AM by Blog57 Team | | (NewsTarget) According to a new study by researchers at the University of Michigan, many prostate cancer patients may be opting for over-aggressive surgery and radiation treatments when milder therapies may be more effective. The researchers examined more than 64,000 medical records for men with early-stage prostate cancer and found that of the 25,000 with very low-risk tumors, half still opted for radiation and surgery treatments. Previous studies have found that closely monitoring the cancer may be the best option for such patients, and in many cases, waiting to treat prostate tumors until it is absolutely necessary may be an even better option. Experts believe many prostate cancer patients overreact to the word "cancer" and subsequently over-treat their condition. "Prostate cancer is different in several ways," says Dr.... | |
| |
| | | Scottish Hospital to Offer Cancer Patients Advanced Radiotherapy Treatments With New Equipment and Software from Varian | | Posted Wednesday, July 19, 2006 2:59:45 AM by Blog57 Team | | GLASGOW, Scotland, July 17 /PRNewswire-FirstCall/ -- Cancer patients in Scotland will have access to the full range of state-of-the-art radiotherapy treatments with the acquisition of advanced new equipment and software by the Beatson West of Scotland Cancer Centre in Glasgow as part of a purchasing wave by the Scottish Executive. Varian has been chosen to supply all the medical linear accelerators awarded to date within this centralised procurement managed by Scottish Healthcare Supplies. When three new Varian Clinac(R) iX accelerators are installed at the amalgamated West of Scotland Cancer Centre early in 2007, it will become the largest radiotherapy unit in the United Kingdom, with eleven accelerators in total. Varian is also supplying the hospital with two On-Board Imager(R) devices for modern image guided radiotherapy (IGRT) treatments, three RPM(TM) respiratory gating systems, an Acuity(R) iX 3D imaging system for brachytherapy planning and verification and three GammaMed(TM) afterloaders for high dose rate (HDR) and pulsed dose rate (PDR) brachytherapy treatments.... | |
| |
| |
|
|
